ObesiD is a new Australian-first resource, articulating the principles of dosage adjustment in patients with obesity and providing evidence-based advice on dosage adjustment for 70 commonly used medicines. By bringing together available evidence, and pharmacokinetic and pharmacodynamic considerations that inform the choice of most appropriate dose for a person with obesity, the resource also supports decision making when there is an absence of evidence.
You’re offline. This is a read only version of the page.
